Are Chandan Healthcare Ltd latest results good or bad?

1 hour ago
share
Share Via
Chandan Healthcare Ltd's latest results show strong revenue growth with net sales up 38.32% year-on-year, but operating margins have compressed due to rising costs. While net profit increased significantly, the company faces challenges with negative operating cash flow and margin sustainability amid its aggressive expansion.
Chandan Healthcare Ltd's latest financial results for Q4 FY26 reflect a complex operational landscape characterized by strong revenue growth alongside margin pressures. The company reported net sales of ₹75.58 crores, marking a year-on-year increase of 38.32% and a sequential growth of 16.26%. This performance underscores the company's successful market penetration in North India's diagnostic services sector, where it operates a network of pathology and radiology facilities.
Net profit for the quarter reached ₹6.92 crores, representing a significant year-on-year growth of 64.76% and a sequential increase of 52.42%. However, despite these positive indicators, the operating margin experienced compression, declining to 16.45% from 18.21% in the previous quarter. This contraction suggests rising operational costs, particularly in employee expenses, which increased notably during the quarter. For the full fiscal year FY25, Chandan Healthcare achieved total revenue of ₹230.00 crores, reflecting a robust year-on-year growth of 30.70%. The operating margin for the year stood at 17.80%, indicating an ability to extract operational leverage despite quarterly fluctuations. The company also demonstrated strong capital efficiency, with a return on equity (ROE) of 21.16%, which is significantly above the peer group average. However, the results also highlighted concerns regarding cash flow dynamics, as the company generated negative operating cash flow of ₹29.00 crores due to a substantial working capital build-up. In terms of evaluation, Chandan Healthcare saw an adjustment in its evaluation, reflecting the complexities of its financial performance amid rapid expansion and operational challenges. The company operates in a competitive and fragmented diagnostic services market, which presents both growth opportunities and risks related to margin sustainability and cash flow management. Overall, Chandan Healthcare's financial results illustrate a company in a phase of aggressive growth, yet facing challenges that require careful management to ensure long-term sustainability and profitability.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News